nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Malnutrition—Thiotepa—sarcoma	0.00419	0.00419	CcSEcCtD
Telbivudine—Hepatitis—Mitoxantrone—sarcoma	0.00415	0.00415	CcSEcCtD
Telbivudine—Pharyngitis—Mitoxantrone—sarcoma	0.00412	0.00412	CcSEcCtD
Telbivudine—Back pain—Thiotepa—sarcoma	0.00405	0.00405	CcSEcCtD
Telbivudine—Neutropenia—Etoposide—sarcoma	0.00404	0.00404	CcSEcCtD
Telbivudine—Neck pain—Epirubicin—sarcoma	0.0039	0.0039	CcSEcCtD
Telbivudine—Musculoskeletal pain—Epirubicin—sarcoma	0.0039	0.0039	CcSEcCtD
Telbivudine—Ill-defined disorder—Dactinomycin—sarcoma	0.00386	0.00386	CcSEcCtD
Telbivudine—Mediastinal disorder—Vincristine—sarcoma	0.00384	0.00384	CcSEcCtD
Telbivudine—Renal failure—Etoposide—sarcoma	0.00378	0.00378	CcSEcCtD
Telbivudine—Neuropathy peripheral—Etoposide—sarcoma	0.00377	0.00377	CcSEcCtD
Telbivudine—Malaise—Dactinomycin—sarcoma	0.00375	0.00375	CcSEcCtD
Telbivudine—Influenza like illness—Epirubicin—sarcoma	0.00375	0.00375	CcSEcCtD
Telbivudine—Cough—Thiotepa—sarcoma	0.00365	0.00365	CcSEcCtD
Telbivudine—Hepatobiliary disease—Etoposide—sarcoma	0.00364	0.00364	CcSEcCtD
Telbivudine—Neck pain—Doxorubicin—sarcoma	0.00361	0.00361	CcSEcCtD
Telbivudine—Musculoskeletal pain—Doxorubicin—sarcoma	0.00361	0.00361	CcSEcCtD
Telbivudine—Back pain—Vincristine—sarcoma	0.00359	0.00359	CcSEcCtD
Telbivudine—Arthralgia—Thiotepa—sarcoma	0.00356	0.00356	CcSEcCtD
Telbivudine—Myalgia—Thiotepa—sarcoma	0.00356	0.00356	CcSEcCtD
Telbivudine—Dysgeusia—Mitoxantrone—sarcoma	0.00354	0.00354	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00354	0.00354	CcSEcCtD
Telbivudine—Myalgia—Dactinomycin—sarcoma	0.00354	0.00354	CcSEcCtD
Telbivudine—Back pain—Mitoxantrone—sarcoma	0.0035	0.0035	CcSEcCtD
Telbivudine—Discomfort—Dactinomycin—sarcoma	0.0035	0.0035	CcSEcCtD
Telbivudine—Influenza like illness—Doxorubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Telbivudine—Hypoaesthesia—Etoposide—sarcoma	0.00344	0.00344	CcSEcCtD
Telbivudine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00335	0.00335	CcSEcCtD
Telbivudine—Nervous system disorder—Thiotepa—sarcoma	0.00335	0.00335	CcSEcCtD
Telbivudine—Sepsis—Epirubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Telbivudine—Thrombocytopenia—Thiotepa—sarcoma	0.00335	0.00335	CcSEcCtD
Telbivudine—Thrombocytopenia—Dactinomycin—sarcoma	0.00332	0.00332	CcSEcCtD
Telbivudine—Skin disorder—Thiotepa—sarcoma	0.00332	0.00332	CcSEcCtD
Telbivudine—Malaise—Mitoxantrone—sarcoma	0.00326	0.00326	CcSEcCtD
Telbivudine—Myalgia—Vincristine—sarcoma	0.00316	0.00316	CcSEcCtD
Telbivudine—Cough—Mitoxantrone—sarcoma	0.00316	0.00316	CcSEcCtD
Telbivudine—Mediastinal disorder—Etoposide—sarcoma	0.00311	0.00311	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00311	0.00311	CcSEcCtD
Telbivudine—Sepsis—Doxorubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00309	0.00309	CcSEcCtD
Telbivudine—Arthralgia—Mitoxantrone—sarcoma	0.00308	0.00308	CcSEcCtD
Telbivudine—Chest pain—Mitoxantrone—sarcoma	0.00308	0.00308	CcSEcCtD
Telbivudine—Myalgia—Mitoxantrone—sarcoma	0.00308	0.00308	CcSEcCtD
Telbivudine—Paraesthesia—Thiotepa—sarcoma	0.00307	0.00307	CcSEcCtD
Telbivudine—Discomfort—Mitoxantrone—sarcoma	0.00304	0.00304	CcSEcCtD
Telbivudine—Dyspepsia—Thiotepa—sarcoma	0.00301	0.00301	CcSEcCtD
Telbivudine—Nervous system disorder—Vincristine—sarcoma	0.00297	0.00297	CcSEcCtD
Telbivudine—Thrombocytopenia—Vincristine—sarcoma	0.00297	0.00297	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00295	0.00295	CcSEcCtD
Telbivudine—Fatigue—Thiotepa—sarcoma	0.00295	0.00295	CcSEcCtD
Telbivudine—Dysgeusia—Etoposide—sarcoma	0.00295	0.00295	CcSEcCtD
Telbivudine—Renal impairment—Epirubicin—sarcoma	0.00294	0.00294	CcSEcCtD
Telbivudine—Fatigue—Dactinomycin—sarcoma	0.00292	0.00292	CcSEcCtD
Telbivudine—Pain—Thiotepa—sarcoma	0.00292	0.00292	CcSEcCtD
Telbivudine—Back pain—Etoposide—sarcoma	0.00291	0.00291	CcSEcCtD
Telbivudine—Pain—Dactinomycin—sarcoma	0.0029	0.0029	CcSEcCtD
Telbivudine—Muscle spasms—Etoposide—sarcoma	0.00289	0.00289	CcSEcCtD
Telbivudine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00289	0.00289	CcSEcCtD
Telbivudine—Skin disorder—Mitoxantrone—sarcoma	0.00287	0.00287	CcSEcCtD
Telbivudine—Feeling abnormal—Thiotepa—sarcoma	0.00282	0.00282	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Telbivudine—Feeling abnormal—Dactinomycin—sarcoma	0.00279	0.00279	CcSEcCtD
Telbivudine—Gastrointestinal pain—Thiotepa—sarcoma	0.00279	0.00279	CcSEcCtD
Telbivudine—Ill-defined disorder—Etoposide—sarcoma	0.00279	0.00279	CcSEcCtD
Telbivudine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00277	0.00277	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00276	0.00276	CcSEcCtD
Telbivudine—Migraine—Epirubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Telbivudine—Insomnia—Vincristine—sarcoma	0.00274	0.00274	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—sarcoma	0.00272	0.00272	CcSEcCtD
Telbivudine—Paraesthesia—Vincristine—sarcoma	0.00272	0.00272	CcSEcCtD
Telbivudine—Malaise—Etoposide—sarcoma	0.00271	0.00271	CcSEcCtD
Telbivudine—Abdominal pain—Thiotepa—sarcoma	0.0027	0.0027	CcSEcCtD
Telbivudine—Body temperature increased—Thiotepa—sarcoma	0.0027	0.0027	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00269	0.00269	CcSEcCtD
Telbivudine—Abdominal pain—Dactinomycin—sarcoma	0.00268	0.00268	CcSEcCtD
Telbivudine—Body temperature increased—Dactinomycin—sarcoma	0.00268	0.00268	CcSEcCtD
Telbivudine—Paraesthesia—Mitoxantrone—sarcoma	0.00265	0.00265	CcSEcCtD
Telbivudine—Cough—Etoposide—sarcoma	0.00262	0.00262	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vincristine—sarcoma	0.00262	0.00262	CcSEcCtD
Telbivudine—Fatigue—Vincristine—sarcoma	0.00261	0.00261	CcSEcCtD
Telbivudine—Dyspepsia—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Telbivudine—Pain—Vincristine—sarcoma	0.00259	0.00259	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Telbivudine—Chest pain—Etoposide—sarcoma	0.00256	0.00256	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Telbivudine—Fatigue—Mitoxantrone—sarcoma	0.00254	0.00254	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00254	0.00254	CcSEcCtD
Telbivudine—Discomfort—Etoposide—sarcoma	0.00253	0.00253	CcSEcCtD
Telbivudine—Pain—Mitoxantrone—sarcoma	0.00252	0.00252	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Telbivudine—Gastrointestinal pain—Vincristine—sarcoma	0.00248	0.00248	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Telbivudine—Asthenia—Thiotepa—sarcoma	0.00245	0.00245	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—sarcoma	0.00244	0.00244	CcSEcCtD
Telbivudine—Asthenia—Dactinomycin—sarcoma	0.00243	0.00243	CcSEcCtD
Telbivudine—Feeling abnormal—Mitoxantrone—sarcoma	0.00243	0.00243	CcSEcCtD
Telbivudine—Influenza—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Telbivudine—Pruritus—Thiotepa—sarcoma	0.00242	0.00242	CcSEcCtD
Telbivudine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00241	0.00241	CcSEcCtD
Telbivudine—Thrombocytopenia—Etoposide—sarcoma	0.0024	0.0024	CcSEcCtD
Telbivudine—Body temperature increased—Vincristine—sarcoma	0.0024	0.0024	CcSEcCtD
Telbivudine—Abdominal pain—Vincristine—sarcoma	0.0024	0.0024	CcSEcCtD
Telbivudine—Skin disorder—Etoposide—sarcoma	0.00238	0.00238	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Telbivudine—Diarrhoea—Thiotepa—sarcoma	0.00234	0.00234	CcSEcCtD
Telbivudine—Body temperature increased—Mitoxantrone—sarcoma	0.00233	0.00233	CcSEcCtD
Telbivudine—Abdominal pain—Mitoxantrone—sarcoma	0.00233	0.00233	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Telbivudine—Diarrhoea—Dactinomycin—sarcoma	0.00232	0.00232	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Telbivudine—Dizziness—Thiotepa—sarcoma	0.00226	0.00226	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Telbivudine—Paraesthesia—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Telbivudine—Asthenia—Vincristine—sarcoma	0.00217	0.00217	CcSEcCtD
Telbivudine—Vomiting—Thiotepa—sarcoma	0.00217	0.00217	CcSEcCtD
Telbivudine—Vomiting—Dactinomycin—sarcoma	0.00216	0.00216	CcSEcCtD
Telbivudine—Rash—Thiotepa—sarcoma	0.00215	0.00215	CcSEcCtD
Telbivudine—Dermatitis—Thiotepa—sarcoma	0.00215	0.00215	CcSEcCtD
Telbivudine—Headache—Thiotepa—sarcoma	0.00214	0.00214	CcSEcCtD
Telbivudine—Rash—Dactinomycin—sarcoma	0.00214	0.00214	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Etoposide—sarcoma	0.00212	0.00212	CcSEcCtD
Telbivudine—Asthenia—Mitoxantrone—sarcoma	0.00212	0.00212	CcSEcCtD
Telbivudine—Fatigue—Etoposide—sarcoma	0.00212	0.00212	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Telbivudine—Pain—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Telbivudine—Diarrhoea—Vincristine—sarcoma	0.00207	0.00207	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Telbivudine—Nausea—Thiotepa—sarcoma	0.00203	0.00203	CcSEcCtD
Telbivudine—Feeling abnormal—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Telbivudine—Diarrhoea—Mitoxantrone—sarcoma	0.00202	0.00202	CcSEcCtD
Telbivudine—Nausea—Dactinomycin—sarcoma	0.00201	0.00201	CcSEcCtD
Telbivudine—Gastrointestinal pain—Etoposide—sarcoma	0.00201	0.00201	CcSEcCtD
Telbivudine—Dizziness—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Telbivudine—Abdominal pain—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Telbivudine—Body temperature increased—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Telbivudine—Vomiting—Vincristine—sarcoma	0.00193	0.00193	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Telbivudine—Rash—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Telbivudine—Dermatitis—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Telbivudine—Headache—Vincristine—sarcoma	0.0019	0.0019	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Telbivudine—Vomiting—Mitoxantrone—sarcoma	0.00188	0.00188	CcSEcCtD
Telbivudine—Rash—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Telbivudine—Dermatitis—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Telbivudine—Headache—Mitoxantrone—sarcoma	0.00185	0.00185	CcSEcCtD
Telbivudine—Nausea—Vincristine—sarcoma	0.0018	0.0018	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Telbivudine—Asthenia—Etoposide—sarcoma	0.00176	0.00176	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Telbivudine—Nausea—Mitoxantrone—sarcoma	0.00175	0.00175	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Telbivudine—Pruritus—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Telbivudine—Diarrhoea—Etoposide—sarcoma	0.00168	0.00168	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Telbivudine—Back pain—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Telbivudine—Dizziness—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Telbivudine—Vomiting—Etoposide—sarcoma	0.00156	0.00156	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Telbivudine—Rash—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Telbivudine—Dermatitis—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Telbivudine—Headache—Etoposide—sarcoma	0.00154	0.00154	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Telbivudine—Malaise—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Telbivudine—Cough—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Telbivudine—Nausea—Etoposide—sarcoma	0.00146	0.00146	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Telbivudine—Cough—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Telbivudine—Pain—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Telbivudine—Pain—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—sarcoma	0.000987	0.000987	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—sarcoma	0.000973	0.000973	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—sarcoma	0.000941	0.000941	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—sarcoma	0.000913	0.000913	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—sarcoma	0.00091	0.00091	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—sarcoma	0.000901	0.000901	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—sarcoma	0.000875	0.000875	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—sarcoma	0.000871	0.000871	CcSEcCtD
Telbivudine—Rash—Epirubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—sarcoma	0.000867	0.000867	CcSEcCtD
Telbivudine—Headache—Epirubicin—sarcoma	0.000862	0.000862	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—sarcoma	0.000842	0.000842	CcSEcCtD
Telbivudine—Nausea—Epirubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Telbivudine—Rash—Doxorubicin—sarcoma	0.000803	0.000803	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Telbivudine—Headache—Doxorubicin—sarcoma	0.000798	0.000798	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—sarcoma	0.000756	0.000756	CcSEcCtD
